Effect of melatonin and metabolites on copper-mediated oxidation of low density lipoprotein

British Journal of Clinical Pharmacology

Volumn 44, Issue 3, 1997, Pages 283-284

  Seeger, Harald ^a   Mueck, Alfred O ^a   Lippert, Theodor H ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Dept of Obstetrics and Gynecology   (Germany)

Author keywords

LDL oxidation; Melatonin; Metabolites

Indexed keywords

6 HYDROXYMELATONIN; ALPHA TOCOPHEROL; MELATONIN; N ACETYLSEROTONIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SEROTONIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID OXIDATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030882965     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00648.x     Document Type: Article

References (7)

1. Arendt J. Melatonin and the mammalian pineal gland. 1995, Chapman & Hall: London.
2. Tan D-X, Chen L-D, Poeggeler B, Manchester LC, Reiter Rj. Melatoinin: a potent, endogenous hydroxyl radical scavenger. Endorrine J 1993; 1: 57-60.
3. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continous monitoring of in vilro oxidation of human low density lipoprotein. Free Rad Res Comm 1989; 6: 67-75.
4. Parthasarathy S, Steinberg D, Witztum JI., The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann Rev Med 1992: 43: 219-225.
5. Steinberg D. Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increases its atherogenicity. N bngl J Med 1989; 320: 915-924.
6. Pierrefiche G, Topall G, Courbain G., Henrier I, Laborit H. Antioxidaot activity of melatonin in mice. Res Comm Chem path pharm 1993; 80: 211-223.
7. Holmes SW, Sugden D. Effects of melatonin on sleep and neurochemistry in the rat. Br J Pharnacol 1982; 76: 95-101.